Cite

HARVARD Citation

    Qiu, W. et al. (2019). A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan. Journal of immunology research. p. . [Online]. 
  
Back to record